Traws Pharma, Inc.
TRAW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001130598
No open-market purchases or sales by Traws Pharma, Inc. insiders were filed in the last 90 days; 34 institutions reported holding it in 13F filings for Q2 2026, worth $5.19M in total; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in Traws Pharma, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 24
- +24 vs. Q1 2021
- Shares held
- 1.57M
- +1.57M vs. Q1 2021
- Total value
- $10.9M
- +$10.9M vs. Q1 2021
- New holders
- 24
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TRAW on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 34 | $5.19M |
| Q1 2026 | 28 | $6.62M |
| Q4 2025 | 22 | $3.86M |
| Q3 2025 | 18 | $2.41M |
| Q2 2025 | 19 | $1.87M |
| Q1 2025 | 19 | $3.98M |
| Q4 2024 | 19 | $10.2M |
| Q3 2024 | 12 | $3.80M |
| Q2 2024 | 30 | $1.36M |
| Q1 2024 | 26 | $1.88M |
| Q4 2023 | 27 | $1.35M |
| Q3 2023 | 28 | $1.27M |
| Q2 2023 | 24 | $2.19M |
| Q1 2023 | 25 | $1.04M |
| Q4 2022 | 29 | $1.01M |
| Q3 2022 | 30 | $1.54M |
| Q2 2022 | 32 | $2.36M |
| Q1 2022 | 28 | $3.60M |
| Q4 2021 | 34 | $6.14M |
| Q3 2021 | 37 | $10.5M |
| Q2 2021 | 24 | $10.9M |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Traws Pharma, Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 680,618 | $4.72M | 0.00% | +680,618 | New |
| BlackRock Inc. | 251,397 | $1.74M | 0.00% | +251,397 | New |
| Geode Capital Management, LLC | 142,980 | $990.0K | 0.00% | +142,980 | New |
| State Street Corp | 115,090 | $798.0K | 0.00% | +115,090 | New |
| Morgan Stanley | 106,786 | $740.0K | 0.00% | +106,786 | New |
| Dimensional Fund Advisors LP | 73,387 | $509.0K | 0.00% | +73,387 | New |
| Northern Trust Corp | 32,298 | $224.0K | 0.00% | +32,298 | New |
| Susquehanna Fundamental Investments, LLC | 24,930 | $173.0K | 0.00% | +24,930 | New |
| Marshall Wace, LLP | 24,345 | $169.0K | 0.00% | +24,345 | New |
| Beacon Pointe Advisors, LLC | 23,987 | $166.0K | 0.01% | +23,987 | New |
| Ikarian Capital, LLC | 23,226 | $161.0K | 0.03% | +23,226 | New |
| Jump Financial, LLC | 18,500 | $128.0K | 0.01% | +18,500 | New |
| Hillcrest Wealth Advisors - NY, LLC | 16,704 | $116.0K | 0.07% | +16,704 | New |
| Deutsche Bank AG | 16,359 | $113.0K | 0.00% | +16,359 | New |
| Two Sigma Advisers, LP | 15,633 | $108.0K | 0.00% | +15,633 | New |
| UBS Group AG | 3,930 | $27.0K | 0.00% | +3,930 | New |
| Emfo, LLC | 3,333 | $23.0K | 0.02% | +3,333 | New |
| Rockefeller Capital Management L.P. | 566 | $3.00K | 0.00% | +566 | New |
| Wells Fargo & Company | 103 | $1.00K | 0.00% | +103 | New |
| Bank of America Corp | 39 | $0 | 0.00% | +39 | New |
| Tower Research Capital LLC (TRC) | 42 | $0 | 0.00% | +42 | New |
| Ironwood Financial, llc | 15 | $0 | 0.00% | +15 | New |
| Advisor Group Holdings, Inc. | 4 | $0 | 0.00% | +4 | New |
| Larson Financial Group LLC | 66 | $0 | 0.00% | +66 | New |